Cardio while dieting cools the inflammation a diet alone leaves behind

Obesity is characterised by chronic low-grade inflammation, a persistent simmer of immune activity that is a major driver of cardiometabolic risk. Energy restriction, meaning a sustained calorie deficit, sits at the centre of obesity treatment, but people are routinely advised to add exercise on top, and it has been unclear whether the type of exercise matters. Specifically, nobody had clearly compared how aerobic exercise, high-intensity interval training and combined training stack up against each other, and against dieting alone, for calming inflammatory markers and improving insulin resistance. This network meta-analysis set out to make those comparisons directly.

The researchers systematically searched for randomised controlled trials that tested energy restriction alone against energy restriction combined with aerobic exercise, high-intensity interval training or combined exercise in participants with overweight or obesity. Twenty-four trials involving 1,694 participants met the criteria. Treatment effects on inflammatory biomarkers and insulin resistance were quantified as standardised mean differences, and the likely hierarchy of treatments was explored with a ranking method that the authors treated as supportive rather than primary evidence.

Compared with energy restriction alone, adding aerobic exercise produced steady incremental improvements across inflammatory endpoints, with favourable effects on CRP (standardised mean difference of -0.52), hs-CRP (-0.32), TNF-α (-0.48) and IL-6 (-0.35). Combined exercise was associated with a greater rise in adiponectin, a hormone linked to metabolic health, with a standardised mean difference of 0.56, though the authors urge caution because that comparison drew on a smaller pool of evidence. Notably, none of the exercise-plus-diet combinations significantly improved HOMA-IR, the study's measure of insulin resistance, beyond the diet alone. No statistical inconsistency was detected across the network, but the power to detect it was limited because several outcome networks were small.

The result fits the broader picture that exercise carries benefits that do not show up on the scale, and it sharpens that picture by showing which markers respond: the anti-inflammatory gains concentrated in the aerobic exercise arm. It also complicates the assumption that adding any exercise to a diet automatically improves insulin resistance, since no modality achieved that here beyond restriction alone. The authors conclude that no single exercise type is universally superior, and the sparse networks behind some comparisons mean the adiponectin finding in particular needs confirming.

For anyone in a deliberate calorie deficit, this is a reason to think of aerobic work as doing a distinct job during the diet: nudging down the inflammatory markers that a deficit alone does not fully address. It is equally a reason to hold realistic expectations, because on this evidence exercise added nothing measurable to the diet's effect on insulin resistance. The absence of a single winning modality also suggests the exercise you will actually sustain matters more than chasing a supposedly optimal format.